On July 19th, IE Life Science handed over the successfully completed production building to Canexis Pharma AG.
The first meeting took place in the first half of 2020, then planning took place for almost a year, with construction taking place for around another year. The new owners as well as the general contractor are very satisfied with the result achieved - and all of this despite the turbulent situation with the Covid-19 pandemic, which was in full swing during implementation, as well as the Ukraine crisis that began shortly before Completion.
The building has areas of over 1800 m2 on three floors. It was specifically tailored to the processes of Canexis Pharma AG and has the following features:
- Class E clean rooms
- ATEX zones II
- Production
- Packaging
- Warehouse
- Logistics
- Administration
The building is used by Canexis Pharma AG to successfully participate in the medical cannabis market. In the future, cannabis medicines will be sold across Europe from Schlattingen - according to the highest demands and quality standards in accordance with EU-GMP, DAB and Ph. Eur.
